Results: 5
Selective Suicide Gene Therapy of Colon Cancer Exploiting the Urokinase Plasminogen Activator Receptor Promoter.
- Published in:
- BioDrugs, 2010, v. 24, n. 2, p. 131, doi. 10.2165/11530840-000000000-00000
- By:
- Publication type:
- Article
Immunotherapy for Cervical Cancer.
- Published in:
- BioDrugs, 2010, v. 24, n. 2, p. 109, doi. 10.2165/11532810-000000000-00000
- By:
- Publication type:
- Article
Pluripotent Human Stem Cells.
- Published in:
- BioDrugs, 2010, v. 24, n. 2, p. 99, doi. 10.2165/11532270-000000000-00000
- By:
- Publication type:
- Article
Bispecific Antibodies for Cancer Immunotherapy.
- Published in:
- BioDrugs, 2010, v. 24, n. 2, p. 89, doi. 10.2165/11530960-000000000-00000
- By:
- Publication type:
- Article
Targeted Therapies in Cancer.
- Published in:
- BioDrugs, 2010, v. 24, n. 2, p. 77, doi. 10.2165/11530830-000000000-00000
- By:
- Publication type:
- Article